Brown Martin S JR 4

What Happened
Martin S. Brown Jr., a director of Cumberland Pharmaceuticals (CPIX), was granted 1,800 shares on 2026-03-18. The reported acquisition price is $2.80 per share, for a total value of $5,040. This transaction is reported as an award/grant (Form 4 code A), meaning the insider received shares rather than selling them.

Key Details

• Transaction date and price: 2026-03-18, 1,800 shares at $2.80 each.
• Total reported value: $5,040.
• Transaction type/code: Award/Grant (A) — acquisition of shares as compensation or award.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes / plan disclosures: No 10b5-1 plan, tax withholding, or other footnotes were provided in the data you supplied.
• Timeliness: Filed 2026-03-20 for a 2026-03-18 transaction — appears to be filed within the typical two-business-day Form 4 window.

Context
Awards to directors are commonly part of compensation plans and may be subject to vesting or other restrictions; the Form 4 entry here does not detail any vesting schedule. Such grants reflect receipt of equity rather than a market purchase; they are informational for investors but do not by themselves indicate immediate buying or selling in the open market. For more detail on vesting or plan terms, check the company’s proxy statement or equity plan disclosures.